Belite Bio News

Belite Bio Analyst Ratings

BenzingaMar 22 23:12

Buy Rating Affirmed on Belite Bio as Tinlarebant Shows Promising Clinical Advancements and Market Potential

TipRanksMar 22 21:25

Buy Rating Justified for Belite Bio, Inc. ADR Amidst Promising DRAGON Trial Progress and Strong Financials

TipRanksMar 21 14:16

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arcellx Inc (ACLX) and AdaptHealth (AHCO)

TipRanksMar 18 19:10

Analysts' Top Healthcare Picks: Belite Bio, Inc. ADR (BLTE), Catalyst Pharma (CPRX)

TipRanksMar 14 19:40

Belite Bio Analyst Ratings

BenzingaMar 13 18:56

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Belite Bio, Inc. ADR (BLTE) and Prothena (PRTA)

TipRanksMar 13 18:20

Belite Bio Analyst Ratings

BenzingaDec 28, 2023 00:43

Maxim Group Initiates Coverage On Belite Bio With Buy Rating, Announces Price Target of $60

BenzingaDec 14, 2023 22:11

Belite Bio Analyst Ratings

BenzingaDec 14, 2023 22:10

Belite Bio's Promising Outlook: Strong 3Q23 Results, Effective STGD1 Treatment & Solid Financial Standing Drive Buy Rating

TipRanksNov 16, 2023 20:20

Belite Bio, Inc. ADR (BLTE) Gets a Buy From Benchmark Co.

TipRanksNov 15, 2023 20:08

Belite Bio Analyst Ratings

BenzingaNov 15, 2023 20:04

Promising Clinical Trials and Stable Financials Bolster Buy Rating for Belite Bio, Inc. ADR

TipRanksNov 15, 2023 19:27

Belite Bio, Inc. Receives Buy Rating Amid Promising Tinlarebant Trial Results and Increased Profitability Forecast

TipRanksNov 8, 2023 13:33

Benchmark Reiterates Buy on Belite Bio, Maintains $57 Price Target

BenzingaNov 8, 2023 01:18

Belite Bio Analyst Ratings

BenzingaNov 8, 2023 01:17

HC Wainwright & Co. Maintains Buy on Belite Bio, Raises Price Target to $59

BenzingaNov 7, 2023 00:46

Belite Bio Analyst Ratings

BenzingaNov 7, 2023 00:43

Analysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Sanofi (SNYNF)

TipRanksOct 30, 2023 19:01